SAMANTHA METTE: Open Payments
NPI 1205477924 · ALLENDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,569 in 87 payments from 20 companies in 2025. Trend: 2023 $2,114 · 2024 $1,881 · 2025 $1,569
Food & beverage: $1,569
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $352 |
| PFIZER INC. | 14 | $267 |
| AstraZeneca Pharmaceuticals LP | 3 | $169 |
| ABBVIE INC. | 13 | $163 |
| Lilly USA, LLC | 9 | $160 |
| Exact Sciences Corporation | 4 | $67 |
| Astellas Pharma US Inc | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: Wegovy, NURTEC ODT, Ozempic, MOUNJARO, BREZTRI, VRAYLAR, JARDIANCE, Veozah.
Industry payments across MI — which companies pay providers there.
